Jun. 25 at 8:08 PM
$GLSI Hate to Say it, but much in life is all about Timing
- GLSI is a years out, same w
$ELTX meanwhile SLS P3 Results are Now Imminent.
$SLS after Many YEARS of the Most Rank Market Manipulation, we are now about to Discover and Realize the TRUE VALUE of GPS - a Revolutionary AML Remision Maintenance Immunotherapy that Prevents Relapse and Extends Survival for over 100,000 Patients Currently in Remission.
$28B TAM
FDA TYPE C manufacture already approved
Pristine Safety Profile
Indefinite Dosing to Relapse 5 years / Compounded Revenue
FDA / EU Orphan / Fast Track / RPRV
IP rights to 2037 MRK BMY Partnerships
009 Secondary Asset with
$5B Comps.
IMMINENT 80th EVENT ANNNOUNCEMENT and Phase 3 Results 5 years in the Making...
